{"id":690362,"date":"2022-09-29T10:14:34","date_gmt":"2022-09-29T14:14:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/"},"modified":"2022-09-29T10:14:34","modified_gmt":"2022-09-29T14:14:34","slug":"biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/","title":{"rendered":"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>WOBURN, Mass., Sept.  29, 2022  (GLOBE NEWSWIRE) &#8212; Biofrontera<\/strong><br \/>\n        <strong> Inc.<\/strong><br \/>\n        <strong> (Nasdaq: BFRI),<\/strong> a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022. Management will also be participating in one-on-one investor meetings at the conference.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: justify;vertical-align: middle;vertical-align: middle\">\n            <strong>Event:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: justify;vertical-align: middle;vertical-align: middle\">Roth Inaugural Healthcare Opportunities Conference<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: justify;vertical-align: middle;vertical-align: middle\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: justify;vertical-align: middle;vertical-align: middle\">Thursday, October 6, 2022<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: justify;vertical-align: middle;vertical-align: middle\">\n            <strong>Time:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: justify;vertical-align: middle;vertical-align: middle\">8:30 a.m. Eastern Time<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">Investors registered for the conference are encouraged to contact their Roth representative to schedule a one-on-one meeting with management during the conference.<\/p>\n<p align=\"justify\">\n        <strong>About Biofrontera Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company\u2019s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OFXQoC6OS3muytQcanMl9GsZaMIBwy0jQbAahm1GIxlcjWvGzLVSULmbssgNtT-QQUXS1xzS5Xaeaibr8LhJF-YO_azZmcixicw9iuIB6JI=\" rel=\"nofollow noopener\" target=\"_blank\">www.biofrontera-us.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong><br \/>\n        <strong>s<\/strong><br \/>\n        <strong>:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Biofrontera Inc.<\/strong><br \/>\n        <br \/>Anke zur M\u00fchlen<br \/>+1 781 486 1539<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c0-yNcUoxkD2Ut_gt--w1dhyHWIkZdQDKsS0R6oespUWHwXJmBftKcWO77vk1BoVc9GWx60gQRRg8d9fzXjxyoJidFNCM0dGw1gLRMfr740=\" rel=\"nofollow noopener\" target=\"_blank\">us-ir@biofrontera.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>LHA Investor Relations<\/strong><br \/>\n        <br \/>Tirth T. Patel<br \/>+1 212 201 6614<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=14VgdraXi1wh_dmxPRJKSNqlGRbMp5FpkNSPDANrGM1i6R5L9XSQYTL3hhaa9v3hz49dplGBXGzgy24eX_AlFg==\" rel=\"nofollow noopener\" target=\"_blank\">tpatel@lhai.com<\/a><\/p>\n<p align=\"center\"># # #<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MmUzYjhhOGEtZGU5OS00ZDUwLWIwOTUtZGVhYzVmN2ZlYjg2LTUwMDA4NTk2Mw==\/tiny\/Biofrontera-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022. Management will also be participating in one-on-one investor meetings at the conference. Event: Roth Inaugural Healthcare Opportunities Conference Date: Thursday, October 6, 2022 Time: 8:30 a.m. Eastern Time Investors registered for the conference are encouraged to contact their Roth representative to schedule a one-on-one meeting with management during the conference. About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-690362","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022. Management will also be participating in one-on-one investor meetings at the conference. Event: Roth Inaugural Healthcare Opportunities Conference Date: Thursday, October 6, 2022 Time: 8:30 a.m. Eastern Time Investors registered for the conference are encouraged to contact their Roth representative to schedule a one-on-one meeting with management during the conference. About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for &hellip; Continue reading &quot;Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T14:14:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference\",\"datePublished\":\"2022-09-29T14:14:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/\"},\"wordCount\":195,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/\",\"name\":\"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==\",\"datePublished\":\"2022-09-29T14:14:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/","og_locale":"en_US","og_type":"article","og_title":"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference - Market Newsdesk","og_description":"WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022. Management will also be participating in one-on-one investor meetings at the conference. Event: Roth Inaugural Healthcare Opportunities Conference Date: Thursday, October 6, 2022 Time: 8:30 a.m. Eastern Time Investors registered for the conference are encouraged to contact their Roth representative to schedule a one-on-one meeting with management during the conference. About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for &hellip; Continue reading \"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-29T14:14:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference","datePublished":"2022-09-29T14:14:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/"},"wordCount":195,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/","name":"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==","datePublished":"2022-09-29T14:14:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjAxMCM1MTc5MjQzIzUwMDA4NTk2Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-present-at-the-roth-inaugural-healthcare-opportunities-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690362","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=690362"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690362\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=690362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=690362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=690362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}